Hutch News

New Science Spotlight Articles

Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
10 NEW January 23, 2023
Optimizing antigen design may improve HIV vaccine efforts

Optimizing antigen design may improve HIV vaccine efforts

From the Pancera, McElrath and Stamatatos labs, Vaccine and Infectious Disease and Clinical Research Divisions
Science Spotlight - June 20, 2022
Using AI to identify potential COVID-19, cancer therapies

Using AI to identify potential COVID-19, cancer therapies

Early findings show current drugs might be repurposed to calm COVID-19’s cytokine storms, treat metastatic prostate cancer
Hutch News - September 30, 2021
Fred Hutch begins experimental COVID-19 vaccine efficacy trial

Fred Hutch begins experimental COVID-19 vaccine efficacy trial

Phase 3 study will determine the efficacy of AstraZeneca vaccine candidate
News Releases - November 09, 2020
Fred Hutch opens COVID-19 Clinical Research Center

Fred Hutch opens COVID-19 Clinical Research Center

Medical director outlines goals for the new facility that will host two treatment trials right away
Hutch News - October 05, 2020
Fred Hutch opens COVID-19 Clinical Research Center

Fred Hutch opens COVID-19 Clinical Research Center

Newly renovated facility is among the first stand-alone centers specifically designed to test novel interventions such as monoclonal antibodies and antivirals to treat and prevent COVID-19
News Releases - October 05, 2020
Fred Hutch honors local HIV cure activists, volunteers

Fred Hutch honors local HIV cure activists, volunteers

Seattle's defeatHIV Community Advisory Board receives impact award
Hutch News - January 24, 2020
Improving HIV clinical trials with mobile technology

Improving HIV clinical trials with mobile technology

From the HIV Vaccine Trials Network, Vaccine and Infectious Disease Division
Science Spotlight - July 15, 2019